AWM
TNYA icon

Atticus Wealth Management’s Tenaya Therapeutics TNYA Stock Holding History

Atticus Wealth Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-43,237
Closed -$30.8K – 201
2025
Q4 		$30.8K Sell
43,237
-1,625
-4% -$2.21K 0.01% 204
2025
Q3 		$72.7K Sell
44,862
-2,942
-6% -$2.96K 0.02% 197
2025
Q2 		$29.2K Hold
47,804
– – 0.01% 373
2025
Q1 		$27.3K Buy
47,804
+42
+0.1% +$41 0.01% 291
2024
Q4 		$68.3K Buy
47,762
+17,199
+56% +$38.6K 0.02% 210
2024
Q3 		$59K Hold
30,563
– – 0.02% 229
2024
Q2 		$94.7K Sell
30,563
-25,949
-46% -$107K 0.03% 173
2024
Q1 		$296K Sell
56,512
-12,812
-18% -$61.3K 0.1% 98
2023
Q4 		$225K Sell
69,324
-10,713
-13% -$23.1K 0.08% 117
2023
Q3 		$204K Sell
80,037
-3,401
-4% -$14.2K 0.08% 125
2023
Q2 		$490K Buy
+83,438
New +$485K 0.18% 78

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Atticus Wealth Management's TNYA Position: Q1 2026 in Review

Atticus Wealth Management sold out of Tenaya Therapeutics (TNYA) in Q1 2026, closing a stake of 43,237 shares — an estimated $30.8K sold.

Atticus Wealth Management first reported a position in TNYA in Q2 2023 and held it in 11 quarters. The position peaked at $490K in Q2 2023. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Atticus Wealth Management reported no remaining Tenaya Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Atticus Wealth Management sold 43,237 Tenaya Therapeutics shares in Q1 2026, an estimated $30.8K.
  • Atticus Wealth Management first reported a position in Tenaya Therapeutics in Q2 2023 and held it in 11 quarters.
  • Atticus Wealth Management's Tenaya Therapeutics position peaked at $490K in Q2 2023.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Atticus Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.